Panbela Therapeutics, Inc. (PBLA) Tops Q3 EPS by 2c

Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q3 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA maintains underperform ratings on six BDC stocks
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue